Duopa 4.63 mg/20 mg per mL enteral suspension Images
Generic Name: carbidopa/levodopa
This medication has been identified as Duopa 4.63 mg/20 mg per mL enteral suspension. It is supplied by AbbVie Inc.
Duopa is used in the treatment of Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Duopa 4.63 mg/20 mg per mL enteral suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Duopa
- Generic Name
- carbidopa/levodopa
- Strength
- 4.63 mg/20 mg per mL enteral suspension
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 00074-3012
See also:
More about Duopa (carbidopa / levodopa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- En español
Patient resources
Other brands
Sinemet, Rytary, Crexont, Sinemet CR, ... +2 more
Professional resources
Other brands
Sinemet, Rytary, Crexont, Sinemet CR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.